Free Trial

iRhythm Technologies (IRTC) Competitors

$98.16
+2.41 (+2.52%)
(As of 06/18/2024 ET)

IRTC vs. TNDM, NVCR, NVRO, TFX, SOLV, GMED, PEN, GKOS, STVN, and INSP

Should you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Tandem Diabetes Care (TNDM), NovoCure (NVCR), Nevro (NVRO), Teleflex (TFX), Solventum (SOLV), Globus Medical (GMED), Penumbra (PEN), Glaukos (GKOS), Stevanato Group (STVN), and Inspire Medical Systems (INSP). These companies are all part of the "surgical & medical instruments" industry.

iRhythm Technologies vs.

Tandem Diabetes Care (NASDAQ:TNDM) and iRhythm Technologies (NASDAQ:IRTC) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

Tandem Diabetes Care has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500.

Tandem Diabetes Care currently has a consensus price target of $51.25, suggesting a potential upside of 19.13%. iRhythm Technologies has a consensus price target of $133.25, suggesting a potential upside of 34.23%. Given Tandem Diabetes Care's stronger consensus rating and higher probable upside, analysts plainly believe iRhythm Technologies is more favorable than Tandem Diabetes Care.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tandem Diabetes Care
0 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.92
iRhythm Technologies
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Tandem Diabetes Care had 2 more articles in the media than iRhythm Technologies. MarketBeat recorded 7 mentions for Tandem Diabetes Care and 5 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.69 beat Tandem Diabetes Care's score of 1.57 indicating that Tandem Diabetes Care is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tandem Diabetes Care
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
iRhythm Technologies
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

iRhythm Technologies has lower revenue, but higher earnings than Tandem Diabetes Care. iRhythm Technologies is trading at a lower price-to-earnings ratio than Tandem Diabetes Care, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tandem Diabetes Care$747.72M3.70-$222.61M-$2.17-19.73
iRhythm Technologies$492.68M6.33-$123.41M-$4.23-23.70

Tandem Diabetes Care has a net margin of -18.37% compared to Tandem Diabetes Care's net margin of -25.33%. iRhythm Technologies' return on equity of -34.38% beat Tandem Diabetes Care's return on equity.

Company Net Margins Return on Equity Return on Assets
Tandem Diabetes Care-18.37% -34.38% -10.91%
iRhythm Technologies -25.33%-69.87%-23.50%

Tandem Diabetes Care received 184 more outperform votes than iRhythm Technologies when rated by MarketBeat users. However, 66.04% of users gave iRhythm Technologies an outperform vote while only 61.22% of users gave Tandem Diabetes Care an outperform vote.

CompanyUnderperformOutperform
Tandem Diabetes CareOutperform Votes
573
61.22%
Underperform Votes
363
38.78%
iRhythm TechnologiesOutperform Votes
389
66.04%
Underperform Votes
200
33.96%

Summary

Tandem Diabetes Care beats iRhythm Technologies on 11 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IRTC vs. The Competition

MetriciRhythm TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$3.12B$3.91B$5.07B$8.47B
Dividend YieldN/A1.79%5.29%4.10%
P/E Ratio-23.7010.48134.8915.39
Price / Sales6.33106.622,269.5865.75
Price / CashN/A46.8430.7829.01
Price / Book14.644.474.864.30
Net Income-$123.41M$4.42M$108.82M$215.40M
7 Day Performance8.15%-0.59%-2.53%-1.04%
1 Month Performance5.74%-3.31%-3.96%-3.35%
1 Year Performance-1.26%-19.51%-2.76%0.83%

iRhythm Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TNDM
Tandem Diabetes Care
3.6364 of 5 stars
$45.45
-4.0%
$51.25
+12.8%
+58.7%$2.94B$747.72M-20.942,400Positive News
NVCR
NovoCure
3.8926 of 5 stars
$21.52
+1.3%
$31.25
+45.2%
-56.1%$2.32B$525.66M-11.891,453Positive News
NVRO
Nevro
1.5105 of 5 stars
$9.26
-2.0%
$19.46
+110.3%
-64.5%$339.93M$430.75M-4.041,215Gap Down
TFX
Teleflex
4.7581 of 5 stars
$209.30
-0.9%
$257.29
+22.9%
-18.5%$9.86B$2.97B33.6014,500Positive News
SOLV
Solventum
0 of 5 stars
$54.13
-3.6%
$65.75
+21.5%
N/A$9.35B$8.25B0.00N/ANews Coverage
GMED
Globus Medical
4.2832 of 5 stars
$65.91
-0.4%
$69.40
+5.3%
+13.7%$8.92B$1.57B102.995,000Positive News
PEN
Penumbra
4.4673 of 5 stars
$187.96
-2.0%
$300.64
+59.9%
-44.5%$7.29B$1.06B79.314,200Gap Up
GKOS
Glaukos
3.0252 of 5 stars
$113.55
+0.1%
$112.27
-1.1%
+65.4%$5.72B$314.71M-39.43907Gap Up
STVN
Stevanato Group
0 of 5 stars
€18.30
-0.8%
N/A-44.2%$5.41B$1.08B33.275,635
INSP
Inspire Medical Systems
4.8239 of 5 stars
$167.11
-0.2%
$253.87
+51.9%
-47.5%$4.97B$660.91M-303.841,011Short Interest ↑
Positive News

Related Companies and Tools

This page (NASDAQ:IRTC) was last updated on 6/18/2024 by MarketBeat.com Staff

From Our Partners